4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001771498-26-000002
Chief Executive Officer gave up 21,714 shares (to pay taxes)
- Chief Executive Officer acquired 47,033 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shea Jacqueline Elizabeth Chief Executive Officer | 2026-02-26 | Option exercise | +18,632 | 78,317 | D | ||
| Shea Jacqueline Elizabeth Chief Executive Officer | 2026-02-26 | Shares withheld for taxes | −8,057 | $1.79 | $14,422 | 70,260 | D |
| Shea Jacqueline Elizabeth Chief Executive Officer | 2026-02-26 | Option exercise | +28,401 | 98,661 | D | ||
| Shea Jacqueline Elizabeth Chief Executive Officer | 2026-02-26 | Shares withheld for taxes | −13,657 | $1.79 | $24,446 | 85,004 | D |
| Derivatives | |||||||
| Shea Jacqueline Elizabeth Chief Executive Officer | 2026-02-26 | Option exercise · Restricted Stock Unit | −18,632 | 18,631 | D | ||
| Shea Jacqueline Elizabeth Chief Executive Officer | 2026-02-26 | Option exercise · Restricted Stock Unit | −28,401 | 56,800 | D | ||
Loading xslF345X05/wk-form4_1772228868.xml…